Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$2.46 - $4.27 $849,750 - $1.47 Million
-345,427 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$1.45 - $4.3 $500,869 - $1.49 Million
345,427 New
345,427 $1.43 Million
Q4 2018

Feb 13, 2019

SELL
$1.92 - $4.1 $480,696 - $1.03 Million
-250,363 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$1.89 - $4.95 $473,186 - $1.24 Million
250,363 New
250,363 $986,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $372M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.